Skip to main content
. 2018 Nov 27;9(93):36613–36624. doi: 10.18632/oncotarget.26400

Figure 3.

Figure 3

Plot (A) and (B) represent the trends of VAF during treatment for DNMT3A and NPM1 in dual mutated patients. Plots (C) and (D) show Kaplan-Meier graphs of FCM-MRD, depicting that FCM-MRD at the end of induction is predictive of inferior OS (C) and RFS (D).